1. Home
  2. ENLV vs NXPL Comparison

ENLV vs NXPL Comparison

Compare ENLV & NXPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENLV
  • NXPL
  • Stock Information
  • Founded
  • ENLV 2005
  • NXPL 1997
  • Country
  • ENLV Israel
  • NXPL United States
  • Employees
  • ENLV N/A
  • NXPL N/A
  • Industry
  • ENLV Biotechnology: Pharmaceutical Preparations
  • NXPL Telecommunications Equipment
  • Sector
  • ENLV Health Care
  • NXPL Telecommunications
  • Exchange
  • ENLV Nasdaq
  • NXPL Nasdaq
  • Market Cap
  • ENLV 25.5M
  • NXPL 22.8M
  • IPO Year
  • ENLV 1995
  • NXPL N/A
  • Fundamental
  • Price
  • ENLV $1.13
  • NXPL $0.81
  • Analyst Decision
  • ENLV Strong Buy
  • NXPL
  • Analyst Count
  • ENLV 2
  • NXPL 0
  • Target Price
  • ENLV $10.00
  • NXPL N/A
  • AVG Volume (30 Days)
  • ENLV 175.2K
  • NXPL 279.2K
  • Earning Date
  • ENLV 08-29-2025
  • NXPL 11-13-2025
  • Dividend Yield
  • ENLV N/A
  • NXPL N/A
  • EPS Growth
  • ENLV N/A
  • NXPL N/A
  • EPS
  • ENLV N/A
  • NXPL N/A
  • Revenue
  • ENLV N/A
  • NXPL $58,766,000.00
  • Revenue This Year
  • ENLV N/A
  • NXPL N/A
  • Revenue Next Year
  • ENLV N/A
  • NXPL N/A
  • P/E Ratio
  • ENLV N/A
  • NXPL N/A
  • Revenue Growth
  • ENLV N/A
  • NXPL N/A
  • 52 Week Low
  • ENLV $0.81
  • NXPL $0.43
  • 52 Week High
  • ENLV $2.10
  • NXPL $2.30
  • Technical
  • Relative Strength Index (RSI)
  • ENLV 57.20
  • NXPL 51.07
  • Support Level
  • ENLV $1.01
  • NXPL $0.77
  • Resistance Level
  • ENLV $1.08
  • NXPL $0.86
  • Average True Range (ATR)
  • ENLV 0.04
  • NXPL 0.06
  • MACD
  • ENLV 0.02
  • NXPL -0.00
  • Stochastic Oscillator
  • ENLV 87.86
  • NXPL 18.47

About ENLV Enlivex Therapeutics Ltd.

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.

About NXPL NextPlat Corp

NextPlat Corp is an e-commerce and healthcare company. Its e-commerce venues form an effective network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.

Share on Social Networks: